By the overexpression of ATP-binding cassette (ABC) transporters, increased ALDH1 activity, increased DNA repair and elevated reactive-oxygen-species (ROS)-scavenging capacity, CSCs are resistant to anti-tumor treatment [20]. The gene discussed is ALDH1A1; the disease is neoplasm.